The Effects of Subgingival Air-polishing, as an Adjunct to Non-surgical Periodontal Treatment on Periodontal Parameters and Patient Satisfaction in Patients With Periodontitis

The Effects of Subgingival Air-polishing, as an Adjunct to Non-surgical Periodontal Treatment on Periodontal Parameters and Patient Satisfaction in Patients With Periodontitis: a Randomized Controlled Trial

Periodontal disease is serious and global chronic disease. The prevalence of periodontal diseases in United Arab Emirates is not clear but data from Dubai Health Authority showed that one in five patients has received periodontal treatment in recent years.

Several studies reported the additional benefits provided by the use of air-polishing devices in combination with ultrasonic debridement in the treatment of gum disease, their use may reduce postoperative pain and discomfort while providing improvement in gum status.

The aim of the study is to compare the effect of removing bacterial deposit (biofilm) from deep tooth pocket using combined air-polishing and conventional pocket debridement versus conventional pocket debridement alone on tooth supporting tissue parameters in patients with advanced gum disease (periodontitis).

Methodology: A total of 22 patients with advanced gum disease will be randomly allocated to two groups: a control group, which will receive conventional pocket debridement and a test group which will receive ultrasonic debridement with air-polishing (Airflow Prophylaxis Master, EMS, Nyon, Switzerland). Gum measurements will be recorded by a masked calibrated examiner at six points for each tooth and patients' postoperative experience and satisfaction will be assessed using special forms.

Inclusion Criteria:

• Aged 18 or over.
• Diagnosed with unstable generalised periodontitis, stage III-IV and grade B or C.
• Good compliance and commitment to attend follow-up review appointments.
• Absence of systemic disease that will may affect the treatment outcome.
• Willing to provide informed consent.

Exclusion Criteria:

• Received periodontal treatment in the last 12 months.
• Received systemic anti-inflammatory or antibiotic in the last 6 months or during the study period.
• Use of medication known to affect the gingival growth.
• Chronic bronchitis.
• Asthma.
• Participants that require prophylactic antibiotic.
• Pregnant or breastfeeding participants